S
SCAI Therapeutics
The dating app that does it all - make friends, meet people, or find a date
About SCAI Therapeutics
Scai Therapeutics operates in the biotechnology sector, focusing on the discovery and development of innovative cancer treatments. The company leverages artificial intelligence (AI) and machine learning to identify and develop novel drug candidates, aiming to improve the efficiency and success rate of cancer drug discovery. Scai Therapeutics primarily serves pharmaceutical companies and research institutions, providing them with advanced tools and insights to expedite their drug development processes. The company operates on a B2B (business-to-business) model, generating revenue through partnerships, licensing agreements, and collaborative research projects. By integrating cutting-edge technology with deep scientific expertise, Scai Therapeutics aims to transform the landscape of cancer treatment and bring new hope to patients worldwide.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Jul 2026 | $11M | $44M | BonAngels · SolidX | ↗ |
| SERIES BOther financing | Jul 2021 | $26M | $105M | LifeCare Partners · IMM Investment · Stonebridge Ventures | — |
Growth signals
Latest recorded traffic for SCAI Therapeutics is 3.2K monthly website visits, up 247.8% over the last three months. SCAI Therapeutics's team grew 0% over the past year.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
SCAI Therapeutics in the Seoul ecosystem
The SCAI Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- LPLifeCare Partners
IMM Investment
Stonebridge Ventures
Series B and later2 investors entered at this stage
BonAngels- SOSolidX
Other known investors1 additional known investor
HB Investment
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about SCAI Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SCAI Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.